Loading…
Based on limited metadata, Clientele, Inc. received an FDA Warning Letter on December 3, 2020, regarding drug products. Without access to the full letter text or specific subject line details, the precise nature of the violations cannot be determined from the available information. The warning was issued under FDA's drug regulatory authority, though the specific issuing office is not identified in this metadata. Additional details about manufacturing, labeling, marketing, or other compliance issues would require review of the complete warning letter.